2-(2,1-benzoxazol-7-yl)-N-(2-cyclopropylpropan-2-yl)-4-methylimidazo[1,5-a]pyrimidine-8-carboxamide;2-(5-chloro-4-fluoro-2-pyridinyl)-N-[(1S)-1-cyclopropylethyl]-4-methylimidazo[1,5-a]pyrimidine-8-carboxamide;N-[(1S)-1-cyclopropylethyl]-4-methyl-2-[5-(trifluoromethoxy)-3-pyridinyl]imidazo[1,5-a]pyrimidine-8-carboxamide;N-(2-cyclopropylpropan-2-yl)-2-(5-fluoro-1H-imidazol-2-yl)-4-methylimidazo[1,5-a]pyrimidine-8-carboxamide;N-(2-cyclopropylpropan-2-yl)-4-methyl-2-(1,2-oxazol-5-yl)imidazo[1,5-a]pyrimidine-8-carboxamide;N-(1-cyclopropyl-2,2,2-trifluoroethyl)-4-methyl-2-(1,2-oxazol-5-yl)imidazo[1,5-a]pyrimidine-8-carboxamide
C108H108ClF8N31O10 — CID 162038625
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(2,1-benzoxazol-7-yl)-N-(2-cyclopropylpropan-2-yl)-4-methylimidazo[1,5-a]pyrimidine-8-carboxamide;2-(5-chloro-4-fluoro-2-pyridinyl)-N-[(1S)-1-cyclopropylethyl]-4-methylimidazo[1,5-a]pyrimidine-8-carboxamide;N-[(1S)-1-cyclopropylethyl]-4-methyl-2-[5-(trifluoromethoxy)-3-pyridinyl]imidazo[1,5-a]pyrimidine-8-carboxamide;N-(2-cyclopropylpropan-2-yl)-2-(5-fluoro-1H-imidazol-2-yl)-4-methylimidazo[1,5-a]pyrimidine-8-carboxamide;N-(2-cyclopropylpropan-2-yl)-4-methyl-2-(1,2-oxazol-5-yl)imidazo[1,5-a]pyrimidine-8-carboxamide;N-(1-cyclopropyl-2,2,2-trifluoroethyl)-4-methyl-2-(1,2-oxazol-5-yl)imidazo[1,5-a]pyrimidine-8-carboxamide
2-(2,1-benzoxazol-7-yl)-N-(2-cyclopropylpropan-2-yl)-4-methylimidazo[1,5-a]pyrimidine-8-carboxamide;2-(5-chloro-4-fluoro-2-pyridinyl)-N-[(1S)-1-cyclopropylethyl]-4-methylimidazo[1,5-a]pyrimidine-8-carboxamide;N-[(1S)-1-cyclopropylethyl]-4-methyl-2-[5-(trifluoromethoxy)-3-pyridinyl]imidazo[1,5-a]pyrimidine-8-carboxamide;N-(2-cyclopropylpropan-2-yl)-2-(5-fluoro-1H-imidazol-2-yl)-4-methylimidazo[1,5-a]pyrimidine-8-carboxamide;N-(2-cyclopropylpropan-2-yl)-4-methyl-2-(1,2-oxazol-5-yl)imidazo[1,5-a]pyrimidine-8-carboxamide;N-(1-cyclopropyl-2,2,2-trifluoroethyl)-4-methyl-2-(1,2-oxazol-5-yl)imidazo[1,5-a]pyrimidine-8-carboxamide (PubChem CID 162038625) has the molecular formula C108H108ClF8N31O10 and a molecular weight of 2187.70 g/mol. Its IUPAC name is 2-(2,1-benzoxazol-7-yl)-N-(2-cyclopropylpropan-2-yl)-4-methylimidazo[1,5-a]pyrimidine-8-carboxamide;2-(5-chloro-4-fluoro-2-pyridinyl)-N-[(1S)-1-cyclopropylethyl]-4-methylimidazo[1,5-a]pyrimidine-8-carboxamide;N-[(1S)-1-cyclopropylethyl]-4-methyl-2-[5-(trifluoromethoxy)-3-pyridinyl]imidazo[1,5-a]pyrimidine-8-carboxamide;N-(2-cyclopropylpropan-2-yl)-2-(5-fluoro-1H-imidazol-2-yl)-4-methylimidazo[1,5-a]pyrimidine-8-carboxamide;N-(2-cyclopropylpropan-2-yl)-4-methyl-2-(1,2-oxazol-5-yl)imidazo[1,5-a]pyrimidine-8-carboxamide;N-(1-cyclopropyl-2,2,2-trifluoroethyl)-4-methyl-2-(1,2-oxazol-5-yl)imidazo[1,5-a]pyrimidine-8-carboxamide.
Molecular Properties
| Compound Name | 2-(2,1-benzoxazol-7-yl)-N-(2-cyclopropylpropan-2-yl)-4-methylimidazo[1,5-a]pyrimidine-8-carboxamide;2-(5-chloro-4-fluoro-2-pyridinyl)-N-[(1S)-1-cyclopropylethyl]-4-methylimidazo[1,5-a]pyrimidine-8-carboxamide;N-[(1S)-1-cyclopropylethyl]-4-methyl-2-[5-(trifluoromethoxy)-3-pyridinyl]imidazo[1,5-a]pyrimidine-8-carboxamide;N-(2-cyclopropylpropan-2-yl)-2-(5-fluoro-1H-imidazol-2-yl)-4-methylimidazo[1,5-a]pyrimidine-8-carboxamide;N-(2-cyclopropylpropan-2-yl)-4-methyl-2-(1,2-oxazol-5-yl)imidazo[1,5-a]pyrimidine-8-carboxamide;N-(1-cyclopropyl-2,2,2-trifluoroethyl)-4-methyl-2-(1,2-oxazol-5-yl)imidazo[1,5-a]pyrimidine-8-carboxamide |
|---|---|
| PubChem CID | 162038625 |
| Molecular Formula | C108H108ClF8N31O10 |
| Molecular Weight | 2187.70 g/mol |
| Exact Mass | 2185.85 |
| IUPAC Name | 2-(2,1-benzoxazol-7-yl)-N-(2-cyclopropylpropan-2-yl)-4-methylimidazo[1,5-a]pyrimidine-8-carboxamide;2-(5-chloro-4-fluoro-2-pyridinyl)-N-[(1S)-1-cyclopropylethyl]-4-methylimidazo[1,5-a]pyrimidine-8-carboxamide;N-[(1S)-1-cyclopropylethyl]-4-methyl-2-[5-(trifluoromethoxy)-3-pyridinyl]imidazo[1,5-a]pyrimidine-8-carboxamide;N-(2-cyclopropylpropan-2-yl)-2-(5-fluoro-1H-imidazol-2-yl)-4-methylimidazo[1,5-a]pyrimidine-8-carboxamide;N-(2-cyclopropylpropan-2-yl)-4-methyl-2-(1,2-oxazol-5-yl)imidazo[1,5-a]pyrimidine-8-carboxamide;N-(1-cyclopropyl-2,2,2-trifluoroethyl)-4-methyl-2-(1,2-oxazol-5-yl)imidazo[1,5-a]pyrimidine-8-carboxamide |
| SMILES | Cc1cc(-c2cc(F)c(Cl)cn2)nc2c(C(=O)N[C@@H](C)C3CC3)ncn12.Cc1cc(-c2cccc3conc23)nc2c(C(=O)NC(C)(C)C3CC3)ncn12.Cc1cc(-c2ccno2)nc2c(C(=O)NC(C)(C)C3CC3)ncn12.Cc1cc(-c2ccno2)nc2c(C(=O)NC(C3CC3)C(F)(F)F)ncn12.Cc1cc(-c2cncc(OC(F)(F)F)c2)nc2c(C(=O)N[C@@H](C)C3CC3)ncn12.Cc1cc(-c2ncc(F)[nH]2)nc2c(C(=O)NC(C)(C)C3CC3)ncn12 |
| InChI | InChI=1S/C21H21N5O2.C19H18F3N5O2.C18H17ClFN5O.C17H19FN6O.C17H19N5O2.C16H14F3N5O2/c1-12-9-16(15-6-4-5-13-10-28-25-17(13)15)23-19-18(22-11-26(12)19)20(27)24-21(2,3)14-7-8-14;1-10-5-15(13-6-14(8-23-7-13)29-19(20,21)22)26-17-16(24-9-27(10)17)18(28)25-11(2)12-3-4-12;1-9-5-15(14-6-13(20)12(19)7-21-14)24-17-16(22-8-25(9)17)18(26)23-10(2)11-3-4-11;1-9-6-11(14-19-7-12(18)22-14)21-15-13(20-8-24(9)15)16(25)23-17(2,3)10-4-5-10;1-10-8-12(13-6-7-19-24-13)20-15-14(18-9-22(10)15)16(23)21-17(2,3)11-4-5-11;1-8-6-10(11-4-5-21-26-11)22-14-12(20-7-24(8)14)15(25)23-13(9-2-3-9)16(17,18)19/h4-6,9-11,14H,7-8H2,1-3H3,(H,24,27);5-9,11-12H,3-4H2,1-2H3,(H,25,28);5-8,10-11H,3-4H2,1-2H3,(H,23,26);6-8,10H,4-5H2,1-3H3,(H,19,22)(H,23,25);6-9,11H,4-5H2,1-3H3,(H,21,23);4-7,9,13H,2-3H2,1H3,(H,23,25)/t;11-;10-;;;/m.00.../s1 |
| InChIKey | YWYZECIBZVVWME-KIBYXFQHSA-N |
| XLogP | 18.57 |
| TPSA | 497.52 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 34 |
| Rotatable Bonds | 25 |
| Heavy Atoms | 158 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2187.70 |
| LogP ≤ 5 | 18.57 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 34 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 162038625 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.